Cargando…
Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysis
In Taiwan, the incidence of upper-tract urothelial carcinomas (UTUCs) is higher than in western countries (20%–31% vs. 5%–10%), as is bilateral disease. The standard management for high-grade UTUC is radical nephroureterectomy with bladder cuff excision and regional lymphadenectomy. The challenges i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539752/ https://www.ncbi.nlm.nih.gov/pubmed/36212396 http://dx.doi.org/10.3389/fonc.2022.985177 |